143 related articles for article (PubMed ID: 10197433)
1. Identification of novel bladder tumour suppressor genes.
Knowles MA
Electrophoresis; 1999 Feb; 20(2):269-79. PubMed ID: 10197433
[TBL] [Abstract][Full Text] [Related]
2. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.
van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC
Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858
[TBL] [Abstract][Full Text] [Related]
3. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer.
Nishiyama H; Takahashi T; Kakehi Y; Habuchi T; Knowles MA
Genes Chromosomes Cancer; 1999 Oct; 26(2):171-5. PubMed ID: 10469456
[TBL] [Abstract][Full Text] [Related]
4. Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31.
Simoneau M; Aboulkassim TO; LaRue H; Rousseau F; Fradet Y
Oncogene; 1999 Jan; 18(1):157-63. PubMed ID: 9926930
[TBL] [Abstract][Full Text] [Related]
5. [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder].
Zheng S; Zhang J; Di X; Xiao Z; Wang D; Li C; He Z; Han N; Guo S; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):161-3. PubMed ID: 11953150
[TBL] [Abstract][Full Text] [Related]
6. Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder.
Edwards J; Duncan P; Going JJ; Watters AD; Grigor KM; Bartlett JM
J Pathol; 2002 Apr; 196(4):380-5. PubMed ID: 11920732
[TBL] [Abstract][Full Text] [Related]
7. Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci.
Habuchi T; Devlin J; Elder PA; Knowles MA
Oncogene; 1995 Oct; 11(8):1671-4. PubMed ID: 7478593
[TBL] [Abstract][Full Text] [Related]
8. Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer.
Takle LA; Knowles MA
Oncogene; 1996 Mar; 12(5):1083-7. PubMed ID: 8649800
[TBL] [Abstract][Full Text] [Related]
9. Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder.
Knowles MA; Habuchi T; Kennedy W; Cuthbert-Heavens D
Cancer Res; 2003 Nov; 63(22):7652-6. PubMed ID: 14633685
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S
Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864
[TBL] [Abstract][Full Text] [Related]
11. The random development of LOH on chromosome 9q in superficial bladder cancers.
van Tilborg AA; de Vries A; de Bont M; Groenfeld LE; Zwarthoff EC
J Pathol; 2002 Nov; 198(3):352-8. PubMed ID: 12375268
[TBL] [Abstract][Full Text] [Related]
12. Bladder neoplasms--regions at chromosome 9 with putative tumour suppressor genes.
Wada T; Berggren P; Steineck G; Adolfsson J; Wijkström H; Norming U; Hansson J; Hemminki K; Larsson P
Scand J Urol Nephrol; 2003; 37(2):106-11. PubMed ID: 12745717
[TBL] [Abstract][Full Text] [Related]
13. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.
Friedrich MG; Erbersdobler A; Schwaibold H; Conrad S; Huland E; Huland H
J Urol; 2000 Mar; 163(3):1039-42. PubMed ID: 10688045
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factors.
Sidransky D; Messing E
Urol Clin North Am; 1992 Nov; 19(4):629-39. PubMed ID: 1441021
[TBL] [Abstract][Full Text] [Related]
15. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
[TBL] [Abstract][Full Text] [Related]
16. Infrequent mutation of TRAIL receptor 2 (TRAIL-R2/DR5) in transitional cell carcinoma of the bladder with 8p21 loss of heterozygosity.
Adams J; Cuthbert-Heavens D; Bass S; Knowles MA
Cancer Lett; 2005 Apr; 220(2):137-44. PubMed ID: 15766588
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of human bladder cancer.
Olumi AF; Skinner EC; Tsai YC; Jones PA
Semin Urol; 1990 Nov; 8(4):270-7. PubMed ID: 1980959
[No Abstract] [Full Text] [Related]
18. Mutation of the 9q34 gene TSC1 in sporadic bladder cancer.
Hornigold N; Devlin J; Davies AM; Aveyard JS; Habuchi T; Knowles MA
Oncogene; 1999 Apr; 18(16):2657-61. PubMed ID: 10353610
[TBL] [Abstract][Full Text] [Related]
19. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease.
Yoon DS; Li L; Zhang RD; Kram A; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B
Oncogene; 2001 Aug; 20(36):5005-14. PubMed ID: 11526485
[TBL] [Abstract][Full Text] [Related]
20. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
